FDA Slowly Chips Away at ANDA Backlog
May 02, 2016 | The number of abbreviated new drug applications (ANDAs) pending review is declining according to the latest numbers from FDA. Instead, FDA is waiting to hear industry responses. RAPS
May 02, 2016 | The number of abbreviated new drug applications (ANDAs) pending review is declining according to the latest numbers from FDA. Instead, FDA is waiting to hear industry responses. RAPS
